Pharming Group to participate in November investor conference
Pharming Group has announced its participation in the Jefferies London Healthcare Conference 2024, scheduled for November 19-21 in London, U.K. CEO Sijmen de Vries will deliver a presentation on Wednesday, November 20 at 08:00 GMT/09:00 CET. The presentation will be accessible via live webcast, with a replay available in the 'Upcoming Events' and 'News' sections of Pharming's website. Interested parties can arrange one-to-one meetings with Pharming's management team by contacting their Investor Relations team or Jefferies representative.
Pharming Group ha annunciato la sua partecipazione alla Jefferies London Healthcare Conference 2024, in programma dal 19 al 21 novembre a Londra, Regno Unito. Il CEO Sijmen de Vries terrà una presentazione mercoledì 20 novembre alle 08:00 GMT/09:00 CET. La presentazione sarà accessibile tramite webcast dal vivo, con una registrazione disponibile nelle sezioni 'Eventi Futuri' e 'Notizie' del sito web di Pharming. Le parti interessate possono organizzare incontri one-to-one con il team di gestione di Pharming contattando il loro team delle Relazioni con gli Investitori o un rappresentante di Jefferies.
Pharming Group ha anunciado su participación en la Jefferies London Healthcare Conference 2024, programada para el 19 al 21 de noviembre en Londres, Reino Unido. El CEO Sijmen de Vries presentará el miércoles 20 de noviembre a las 08:00 GMT/09:00 CET. La presentación será accesible a través de una transmisión en vivo, con una repetición disponible en las secciones 'Próximos Eventos' y 'Noticias' del sitio web de Pharming. Las partes interesadas pueden organizar reuniones uno a uno con el equipo de gestión de Pharming contactando a su equipo de Relaciones con Inversores o a un representante de Jefferies.
Pharming Group은 Jefferies London Healthcare Conference 2024에 참여한다고 발표했습니다. 이 회의는 11월 19일부터 21일까지 영국 런던에서 열릴 예정입니다. CEO Sijmen de Vries는 11월 20일 수요일 오전 08:00 GMT/09:00 CET에 발표를 진행할 예정이며, 프레젠테이션은 라이브 웹캐스트를 통해 접근 가능합니다. 발표의 재생은 Pharming 웹사이트의 '향후 이벤트' 및 '뉴스' 섹션에서 확인할 수 있습니다. 관심 있는 분들은 Pharming 경영팀과 1:1 미팅을 조율하기 위해 Investor Relations 팀이나 Jefferies 대표에게 연락할 수 있습니다.
Pharming Group a annoncé sa participation à la Jefferies London Healthcare Conference 2024, qui se déroulera du 19 au 21 novembre à Londres, Royaume-Uni. Le CEO Sijmen de Vries fera une présentation le mercredi 20 novembre à 08:00 GMT/09:00 CET. La présentation sera accessible via un webcast en direct, avec un replay disponible dans les sections 'Événements à venir' et 'Actualités' du site de Pharming. Les parties intéressées peuvent organiser des réunions individuelles avec l'équipe de direction de Pharming en contactant leur équipe des Relations Investisseurs ou un représentant de Jefferies.
Pharming Group hat seine Teilnahme an der Jefferies London Healthcare Conference 2024 bekannt gegeben, die vom 19. bis 21. November in London, Großbritannien, stattfinden wird. CEO Sijmen de Vries wird am Mittwoch, den 20. November um 08:00 GMT/09:00 CET eine Präsentation halten. Die Präsentation wird über einen Live-Webcast zugänglich sein, mit einer Wiederholung in den Bereichen 'Zukünftige Veranstaltungen' und 'Nachrichten' auf der Website von Pharming. Interessierte Parteien können Einzelgespräche mit dem Management-Team von Pharming vereinbaren, indem sie das Investor-Relations-Team oder einen Vertreter von Jefferies kontaktieren.
- None.
- None.
Leiden, the Netherlands, November 5, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will participate in the following investor conference in the month of November:
- Jefferies London Healthcare Conference 2024, London, U.K., November 19-21
Sijmen de Vries, Chief Executive Officer, will present on Wednesday, November 20 at 08:00 GMT/09:00 CET. A live webcast and replay of the presentation will be available in the “Upcoming Events” and “News” sections of Pharming’s website.
For more information about this conference, or to schedule a one-to-one meeting with Pharming’s management team, please contact Pharming’s Investor Relations team at investor@pharming.com or your Jefferies representative.
About Pharming Group N.V.
Pharming Group N.V. (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. Pharming is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines, including small molecules and biologics. Pharming is headquartered in Leiden, the Netherlands, and has employees around the globe who serve patients in over 30 markets in North America, Europe, the Middle East, Africa, and Asia-Pacific.
For more information, visit www.pharming.com and find us on LinkedIn.
For further public information, contact:
Pharming Group, Leiden, the Netherlands
Michael Levitan, VP Investor Relations & Corporate Communications
T: +1 (908) 705 1696
E: investor@pharming.com
FTI Consulting, London, United Kingdom
Victoria Foster Mitchell/Alex Shaw/Amy Byrne
T: +44 203 727 1000
LifeSpring Life Sciences Communication, Amsterdam, the Netherlands
Leon Melens
T: +31 6 53 81 64 27
E: pharming@lifespring.nl
Attachment
FAQ
When is Pharming Group (PHARM) presenting at the Jefferies London Healthcare Conference 2024?
How can investors watch Pharming Group's (PHARM) presentation at the Jefferies Conference?
How can investors schedule meetings with Pharming Group (PHARM) management at the Jefferies Conference?
